JETEMA Co.,Ltd. Logo

JETEMA Co.,Ltd.

Develops and manufactures toxins, fillers, and threads for the aesthetic medicine market.

216080 | KO

Overview

Corporate Details

ISIN(s):
KR7216080002
LEI:
Country:
South Korea
Address:
강원도 원주시 지정면 조엄로 321, 원주시

Description

JETEMA Co., Ltd. is a research-driven biopharmaceutical company specializing in the development and manufacturing of innovative medicines and medical devices for the aesthetic medicine market. The company's core product portfolio includes botulinum toxins, hyaluronic acid-based dermal fillers, and lifting threads. With a strong focus on research and development, JETEMA aims to provide advanced solutions for anti-aging and aesthetic enhancement. The company's name is derived from the Latin word 'Zetéma', meaning 'research', reflecting its commitment to scientific innovation in creating products for a healthy and beautiful life.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2021-04-16 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean 25.1 KB
2021-04-16 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean 23.5 KB
2021-04-06 00:00
투자판단관련주요경영사항(에피티콘 러시아 품목허가 승인 )
Korean 6.5 KB
2021-04-02 00:00
주식매수선택권부여에관한신고
Korean 12.8 KB
2021-04-01 00:00
투자판단관련주요경영사항(제테마더톡신주 100단위의 미간주름개선 제1상 임상시험 종료 )
Korean 10.2 KB
2021-04-01 00:00
투자판단관련주요경영사항(제테마더톡신주 100단위의 미간주름개선 제3상 임상시험계획 IND 신청 )
Korean 13.5 KB
2021-03-29 00:00
정기주주총회결과
Korean 20.1 KB
2021-03-26 00:00
투자판단관련주요경영사항(e.p.t.q. 리도카인 S100(필러)외 2건 러시아 품목허가 승인)
Korean 6.9 KB
2021-03-19 00:00
감사보고서제출
Korean 18.6 KB
2021-03-19 00:00
사업보고서 (2020.12)
Korean 494.7 KB
2021-03-10 00:00
주주총회소집공고
Korean 75.5 KB
2021-03-10 00:00
의결권대리행사권유참고서류
Korean 84.5 KB
2021-03-04 00:00
주주총회소집결의
Korean 11.8 KB
2021-02-24 00:00
기타경영사항(특허권취득)(자율공시)
Korean 4.7 KB
2021-01-29 00:00
매출액또는손익구조30%(대규모법인은15%)이상변동
Korean 13.4 KB

Automate Your Workflow. Get a real-time feed of all JETEMA Co.,Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for JETEMA Co.,Ltd.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for JETEMA Co.,Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

ABEONA THERAPEUTICS INC. Logo
A clinical-stage biopharma developing cell and gene therapies for rare diseases.
United States of America
ABEO
ABINGDON HEALTH PLC Logo
A CDMO specializing in lateral flow assays, offering development to manufacturing services.
United Kingdom
ABDX
ABIONYX Pharma Logo
Develops biotherapies and drug delivery vectors using apolipoprotein A-I.
France
ABNX
ABIVAX Logo
Clinical-stage biotech developing therapeutics for chronic inflammatory diseases.
France
ABVX
Abivax S.A. Logo
Clinical-stage biotech developing miRNA therapeutics for inflammatory diseases.
United States of America
ABVX
ABL Diagnostics Logo
Develops molecular diagnostic solutions for managing infectious diseases.
France
ABLD
Abliva Logo
Biopharmaceutical company developing medicines for primary mitochondrial diseases.
Sweden
ABLI
AB Science Logo
Researches and develops protein kinase inhibitors for human and veterinary medicine.
France
AB
ABVC BIOPHARMA, INC. Logo
Develops botanical drugs and medical devices for oncology, ophthalmology, and CNS.
United States of America
ABVC
ACADIA PHARMACEUTICALS INC Logo
Biopharmaceutical company developing medicines for CNS disorders and rare diseases.
United States of America
ACAD

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.